|
SOHO |
||
|
|
17 MAY 2025 |
|
|
09:00 – 10:00 |
Oral Communications Sessions - Chairs: Handan Haydaroğlu Şahin |
|
|
09:00 – 09:10 |
Flt3 Mutational Analysis In Acute Myeloıd Leukemia |
Rim Frikha |
|
09:10 – 09:20 |
Long-Term Outcomes Of Nivolumab 40 Mg Vs 3 Mg/Kg In Relapsed/Refractory Classic Hodgkin Lymphoma: A Matched Cohort Study |
Liudmila Fedorova (Virtual) |
|
09:20 – 09:30 |
Does Body Mass Index Affects Stem Cell Yield In Healthy Donors? |
Uğur Hatipoğlu |
|
09:30 – 09:40 |
Chronic Pancreatitis Induced By Nilotinib: A Case Of Drug-Related Pancreatic Toxicity in Chronic Myeloid Leukemia |
Naciye Nur Tozluklu |
|
09:40 – 09:50 |
Prognostic Significance Of Neutrophl And Monocyte Counts in Chronic Lymphocytic Leukemia |
Meryem Şener |
|
09:50 – 10:00 |
Why Does Myeloid Malignancy Develop After Lymphoid Malignancy? What Triggers İt? |
Gülşah Akyol |
|
10:00 - 10:15 |
OPENING REMARKS
Birol Güvenç, Elias Jabbour |
|
|
10:15 - 11:25 |
ALL Session Chairs: Serdar Bedii Omay - Mesut Ayer |
|
|
10:15 - 10:30 |
How Do I Treat Newly Diagnosed Ph-Negative ALL |
Hagop Kantarjian |
|
10:30 - 10:45 |
How Do I Treat R-R ALL |
Elias Jabbour |
|
10:45 - 11:00 |
Management of Ph-Like ALL and ETP |
Sabina Chiaretti (Virtual) |
|
11:00 - 11:15 |
How Do I Treat Ph-Positive ALL |
Elias Jabbour |
|
11:15 - 11:25 |
Q&A |
|
|
11:25 - 11:55 |
Coffee Break With Poster Views Chairs: Didar Yanardağ Açık |
|
|
PP - 01 |
Real-World Efficacy And Safety Of Ruxolitinib in Steroid-Refractory Graft-Versus-Host Disease: A Multicenter Retrospective Study From Türkiye |
Mehmet Bakırtaş |
|
PP – 02 |
Jak Inhibitors In T-Cell Lymphomas, A Case-Based Perspective |
Esra Pirinççi |
|
PP – 03 |
Follicular Lymphoma As An Etiology Of Chylous Ascites |
Hatice Gözde Çilek |
|
PP – 04 |
Burkitt Leukemia (All-L3) Presenting With Facial Paralysis And Ptosis in An Elderly Patient: A Rare Case |
Songül Beskisiz Dönen |
|
PP – 05 |
Mantle Cell Lymphoma And Cisplatın-Induced Hyponatremia: A Case Report |
Songül Beskisiz Dönen |
|
PP – 06 |
A Case Of Nilotinib Associated Acute Pancreatitis |
Vehbi Demircan |
|
PP – 07 |
Iron Deficiency Anemia: Study Of Causative And Associated Factors From The Sultanate Of Oman |
Ikhlas Albusaidi |
|
|
CML Session Chairs: Leylagül Kaynar - Güven Yılmaz |
|
|
11:55 - 12:10 |
How Do I Treat Newly Diagnosed CML |
Hagop Kantarjian |
|
12:10 - 12:25 |
How Do I Treat R-R CML |
Elias Jabbour |
|
12:25 - 12:40 |
TFR When and Where |
Giuseppe Saglio |
|
12:40 - 12:50 |
Q&A |
|
|
12:50 - 13:50 |
LUNCH BREAK |
|
|
|
AML Session Chairs: Rıdvan Ali - Şebnem İzmir Güner |
|
|
13:50 - 14:05 |
How Do Treat Newly Diagnosed Young Fit AML |
Naval Daver |
|
14:05 - 14:20 |
How Do I Treat Older/Unfit AML |
Tapan Kadia |
|
14:20 - 14:35 |
Novel Targeted Therapies |
Naval Daver |
|
14:35 - 14:50 |
Role of Allogeneic Stem Cell Transplantation in AML |
Serdar Bedii Omay |
|
14:50 - 15:05 |
MRD and Maintenance in AML |
Tapan Kadia |
|
15:05 - 15:15 |
Q&A |
|
|
15:15 - 15:45 |
Coffee Break With Poster Views / Chairs: Müzeyyen Aslaner |
|
|
PP - 01 |
Incidence And Risk Factors Of Infectious Complications in Patıents With Acute Gvhd After Post-Transplant Cyclophosphamide-Based Prophylaxis
|
Aleksandr Siniaev
|
|
PP – 02 |
Outcome Of Haploidentical Hematopoietic Stem Cell Transplantation İn Resource Limited Setting
|
Khadija Bano
|
|
PP – 03 |
Pre-Transplant Ganciclovir Prophylaxis To Prevent CMV Infections İn Allogeneic Hematopoietic Stem Cell Transplant Recipients
|
Khadija Bano
|
|
PP – 04 |
Gılterıtınıb Experience in Relapsed/Refractory Flt3-Mutated Aml Patients After Allogeneic Transplant: Two Cases |
Serdar Bedii Omay |
|
PP – 05 |
The Duality Of Myeloid Diseases: Langerhans Cell Histiocytosis in A Patient With Primary Myelofibrosis |
Mihriban Yıldırım |
|
PP – 06 |
Cisplatin Induced Cardiomyopathy After Salvage Chemotherapy For Non-Hodgkin Lymphoma |
Fehmi Hindilerden |
|
PP – 07 |
A Case Of Prımary Cns Lymphoma With Corpus Callosum Involvement And Memory Impairment
|
Ali Turunç |
|
PP - 08 |
A Case Of Achalasia After Allogeneic Haematopoietic Stem Cell Transplantation
|
Ali Turunç |
|
|
CLL Session Chairs: Emin Kaya, Figen Atalay |
|
|
15:45 - 16:00 |
How to Optmize Frontline Therapy in CLL |
Nitin Jain |
|
16:00 - 16:15 |
MRD in CLL: Ready For Primetime |
Antonio Cuneo (Virtual) |
|
16:15 – 16.30 |
How Do I Treat R-R CLL |
Nitin Jain |
|
16:30 – 16:40 |
Q&A |
|
|
|
MDS Session Chairs: Güven Çetin - Düzgün Özatlı |
|
|
16:40 – 16:55 |
Biology of MDS and Revised Classification |
Rami Komrokji |
|
16:55 – 17:10 |
Updates on Low-Risk MDS |
Guillermo Garcia-Manero (Virtual) |
|
17:10 – 17:25 |
Updates on High-Risk MDS |
Guillermo Garcia-Manero (Virtual) |
|
17:25 – 17:35 |
Q&A |
|
|
|
18 MAY 2025 |
|
|
07:50 - 09:00 |
Oral Communications Sessions - Chairs: Zahit Bolaman |
|
|
07:50 – 08:00 |
Progression Of Polycythemia Vera To Acute Myeloid Leukemia Following Long-Term Hydroxyurea Therapy: A Case Study |
Bengisu Ece Duman |
|
08:00-08:10 |
Retrospective Analysis Of Primary Breast Lymphomas: A Single Center Experience |
Zehra Akşit Bozkına |
|
08:10-08:20 |
Predıctors Of Response To Ruxolitinib Therapy In Patıents With Myelofibrosis |
Irina Turtanova |
|
08:20-08:30 |
Bleedıng Wıthout Warning: The Hidden Risk Of Hydroxyurea Induced Wunderlıch Syndrome In Myeloprolıferatıve Dısorder |
Veysel Erol |
|
08:30-08:40 |
Venetoclax-Based Versus 7+3 Induction Therapy in Fit Younger Adults With Newly Diagnosed Non-Cbf Aml |
Dmitrii Zhogolev (Virtual) |
|
08:40-08:50 |
Hope Or Hazard? The Safety Profile Of Roxadustat in Anemic Patients |
Ahmet Sarıcı |
|
08:50-09:00 |
Does Neutrophil-To- Lymphocyte Ratio Predict Overal Survival in Primary Myelofibrosis. |
Elmir Guluyev |
|
|
MPN Session Chairs: Mehmet Sönmez – Hüseyin Saffet Beköz |
|
|
09:00 - 09:15 |
Classification of MPN |
Haifa Kathrin Al-Ali |
|
09:15 - 09:30 |
Novel Strategies in MF |
Rami Komrokji |
|
09:30 - 09:45 |
How I Treat PV/ET |
Tariq Mughal |
|
09:45 - 09:55 |
Q&A |
|
|
09:55 - 10:25 |
ALEXION SATALITE SYMPOSIUM PNH and Eculizumab Treatment Chair : Orhan Ayyıldız Speaker : Mehmet Yılmaz |
|
|
10:25 - 10:55 |
Coffee Break With Poster Views / Chairs: Güçhan Alanoğlu |
|
|
PP - 01 |
Which Cancer Will Receive Priority Treatment: A Man With Synchronous High-Grade Lymphoma And Non-Small Cell Lung Cancer |
Ulviyya Hasanzade |
|
PP – 02 |
A Case Of Multıple Serıal Treatment-Resıstant Prımary Medıastınal B Cell Lymphoma Wıth Near Complete Response To Nıvolumab Plus Brentıxumab Vedotın
|
Ceren Uzunoğlu Güren
|
|
PP – 03 |
Wasp Venom Has A Killing Effect On Leukemic Cells
|
Zahit Bolaman
|
|
PP – 04 |
A Case Of Lung Cancer Mimicking Multiple Myeloma And Myelodysplastic Syndrome: A Diagnostic Challenge |
Candaş Mumcu |
|
PP – 05 |
A Rare Case Of Chronic Myeloid Leukemia With Myelofibrosis Transformation And Persistent Splenomegaly Refractory To Multiple Lines Of Therapy |
Naciye Nur Tozluklu |
|
PP – 06 |
A Rare Case Of Chronic Lymphocytic Leukemia With Subsequent Diagnosis Of Chronic Myeloid Leukemia: A Diagnostic And Therapeutic Challenge |
Naciye Nur Tozluklu |
|
PP – 07 |
The Significance Of Mild Cytopenia: A Case Of Low-Grade B-Cell Lymphoid Neoplasia Diagnosed After Five Years Of Unexplained Neutropenia |
Feride Aslanca |
|
|
MM Session Chairs: Ayse Tulin Tuglular – Alpay Yeşilaltay |
|
|
10:55 - 11:10 |
How I Treat Fit Newly Diagnosed MM |
Angelo Maiolino (Virtual) |
|
11:10 - 11:25 |
How I Treat Unfit Newly Diagnsoed MM |
Claudio Cerhione |
|
11:25 - 11:40 |
Management of R-R Disease |
Angelo Maiolino (Virtual) |
|
11:40 - 11:50 |
Q&A |
|
|
|
NHL Session Chairs: Orhan Ayyıldız - Mahmut Töbü |
|
|
11:50 - 12:05 |
Updates on DLBCL |
Massimo Federico |
|
12:05 - 12:20 |
Updates on MCL |
Elif Gülsüm Ümit |
|
12:20 - 12:35 |
Updates on Follicular Lymphoma |
Tayfur Toptaş |
|
12:35 - 12:50 |
Updates on Hodgkin Disease |
Valeh Huseynov |
|
12:50 - 13:00 |
Q&A |
|
|
13:00 |
CLOSING REMARKS |
|
